CERITINIB
ceritinib 150 mg capsule, 3 x 50
CERITINIB (11056X)
11056X
Manner of administration:Oral
Restriction
Indication: Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer
(NSCLC)
Treatment phase: Initial treatment
Restriction
Indication: Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer
(NSCLC)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 150 | # of repeats: 3 | DPMQ: $6,934.82 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Zykadia | |||||